ORBIMED ADVISORS LLC 13D/13G Filings for Forte Biosciences, Inc. (FBRX)

ORBIMED ADVISORS LLC 13D and 13G filings for Forte Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
4:22 pm
Sale		 2021-12-31 13G Forte Biosciences, Inc.
FBRX		 ORBIMED ADVISORS LLC 0
0.000%		 -25,431decrease
(Position Closed)		 Filing
2021-02-12
4:48 pm
Purchase		 2020-12-31 13G Forte Biosciences, Inc.
FBRX		 ORBIMED ADVISORS LLC 25,431
4.740%		 25,431increase
(New Position)		 Filing